[18F] PI-2620

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	2

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04906590 (ClinicalTrials.gov)	August 30, 2021	13/5/2021	PPMI Tau PET Imaging	Assessment of Brain Tau Burden in Participants With Parkinson's Disease in the PPMI Study (PPMI Tau ...	Parkinson Disease	Drug: [18F] PI-2620	Michael J. Fox Foundation for Parkinson's Research	Institute for Neurodegenerative Disorders	Recruiting	30 Years	100 Years	All	35	Phase 2	United States
2	NCT03510572 (ClinicalTrials.gov)	June 4, 2018	17/4/2018	Evaluation of [18F]PI-2620as a Potential Positron Emission Computed Tomography Radioligand for Imagi ...	Clinical Evaluation of [18F]PI-2620Positron Emission Computed Tomography for Imaging Tau Protein in ...	Healthy Volunteer;Alzheimer Disease;Frontotemporal Dementia;Parkinson Disease	Drug: [18F]PI-2620	Asan Medical Center	Korea Health Industry Development Institute	Completed	40 Years	80 Years	All	20	Early Phase 1	Korea, Republic of

First Previous1Next Last